Alpha Cognition Inc. Common Stock
ACOGAlpha Cognition Inc. (ACOG) is a biotechnology company focused on the development of innovative therapies for neurodegenerative diseases, including Alzheimer’s disease. The company leverages cutting-edge research to create treatments aimed at improving cognitive function and addressing unmet medical needs in neurological health.
Company News
Alpha Cognition reported Q1 2026 revenue of $3.5 million, up 40% sequentially, driven by ZUNVEYL Alzheimer's drug sales. The company expanded its prescriber base to 1,060 healthcare professionals (23% growth) and nursing home penetration to 914 facilities (25% growth). With a fully staffed 60-person sales team and three ongoing clinical studies, ...
OTC Markets Group reported the performance of its OTCQX and OTCQB indexes in Q4 2024. The OTCQX Composite Index, OTCQX Billion+ Index, and OTCQX Dividend Index all declined, while the OTCQX Banks Index and OTCQX U.S. Index saw gains. Several companies moved from the OTC markets to major exchanges during the quarter.
